PortfoliosLab logoPortfoliosLab logo
ENTA vs. QVCGA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ENTA vs. QVCGA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enanta Pharmaceuticals, Inc. (ENTA) and QVC Group Inc (QVCGA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


ENTA

1D
-4.22%
1M
3.95%
6M
4.36%
YTD
-16.55%
1Y
74.54%
3Y*
-11.21%
5Y*
-20.55%
10Y*
-5.08%
ALL TIME*
-0.73%

QVCGA

1D
0.00%
1M
0.00%
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ENTA vs. QVCGA - Yearly Performance Comparison


2026 (YTD)
ENTA
Enanta Pharmaceuticals, Inc.
-0.23%
QVCGA
QVC Group Inc
0.00%

Fundamentals

Market Cap

ENTA:

$305.53M

QVCGA:

$2.69M

EPS

ENTA:

-$2.60

QVCGA:

-$301.98

PS Ratio

ENTA:

4.54

QVCGA:

0.00

Total Revenue (TTM)

ENTA:

$69.21M

QVCGA:

$9.23B

Gross Profit (TTM)

ENTA:

$33.44M

QVCGA:

$2.89B

EBITDA (TTM)

ENTA:

-$61.85M

QVCGA:

$789.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ENTA vs. QVCGA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ENTA
ENTA Risk / Return Rank: 7979
Overall Rank
ENTA Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
ENTA Sortino Ratio Rank: 8585
Sortino Ratio Rank
ENTA Omega Ratio Rank: 8484
Omega Ratio Rank
ENTA Calmar Ratio Rank: 8181
Calmar Ratio Rank
ENTA Martin Ratio Rank: 7676
Martin Ratio Rank

QVCGA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENTA vs. QVCGA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enanta Pharmaceuticals, Inc. (ENTA) and QVC Group Inc (QVCGA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ENTAQVCGADifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.29

Calmar ratioReturn relative to maximum drawdown

2.18

Martin ratioReturn relative to average drawdown

3.95

ENTA vs. QVCGA - Sharpe Ratio Comparison


Loading charts...

Drawdowns

ENTA vs. QVCGA - Drawdown Comparison

The maximum ENTA drawdown since its inception was -96.63%, which is greater than QVCGA's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for ENTA and QVCGA.


Loading charts...

Drawdown Indicators


ENTAQVCGADifference

Max Drawdown

Largest peak-to-trough decline

-96.63%

0.00%

-96.63%

Max Drawdown (1Y)

Largest decline over 1 year

-34.30%

Max Drawdown (3Y)

Largest decline over 3 years

-78.51%

Max Drawdown (5Y)

Largest decline over 5 years

-95.62%

Max Drawdown (10Y)

Largest decline over 10 years

-96.63%

Current Drawdown

Current decline from peak

-89.59%

0.00%

-89.59%

Average Drawdown

Average peak-to-trough decline

-49.56%

0.00%

-49.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.94%

Volatility

ENTA vs. QVCGA - Volatility Comparison


Loading charts...

Volatility by Period


ENTAQVCGADifference

Volatility (1M)

Calculated over the trailing 1-month period

14.22%

Volatility (6M)

Calculated over the trailing 6-month period

34.52%

Volatility (1Y)

Calculated over the trailing 1-year period

109.43%

0.00%

+109.43%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

73.65%

0.00%

+73.65%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.78%

0.00%

+60.78%

Dividends

ENTA vs. QVCGA - Dividend Comparison

Neither ENTA nor QVCGA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ENTA vs. QVCGA - Financials Comparison

This section allows you to compare key financial metrics between Enanta Pharmaceuticals, Inc. and QVC Group Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
17.16M
2.68B
(ENTA) Total Revenue
(QVCGA) Total Revenue
Values in USD except per share items
Portfolio Optimizer

Find the right allocation for ENTA and QVCGA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer